The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Necrotising Enterocolitis-Global Market Insights and Sales Trends 2024
Synopsis
Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
The global Necrotising Enterocolitis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Necrotising Enterocolitis in various end use industries. The expanding demands from the Hospital & Clinic and Diagnostic Center, are propelling Necrotising Enterocolitis market. Stage I, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stage II segment is estimated at % CAGR for the next seven-year period.
Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Necrotising Enterocolitis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Necrotising Enterocolitis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Necrotising Enterocolitis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Necrotising Enterocolitis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Necrotising Enterocolitis covered in this report include GlaxoSmithKline, Pfizer, Eli Lilly And Company, Bayer HealthCare, Becton, Dickinson And Company, Bristol-Myers Squibb Company and Medtronic, etc.
The global Necrotising Enterocolitis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Pfizer
Eli Lilly And Company
Bayer HealthCare
Becton, Dickinson And Company
Bristol-Myers Squibb Company
Medtronic
Global Necrotising Enterocolitis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Necrotising Enterocolitis market, Segment by Type:
Stage I
Stage II
Stage III
Global Necrotising Enterocolitis market, by Application
Hospital & Clinic
Diagnostic Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Necrotising Enterocolitis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
The global Necrotising Enterocolitis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Necrotising Enterocolitis in various end use industries. The expanding demands from the Hospital & Clinic and Diagnostic Center, are propelling Necrotising Enterocolitis market. Stage I, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stage II segment is estimated at % CAGR for the next seven-year period.
Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Necrotising Enterocolitis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Necrotising Enterocolitis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Necrotising Enterocolitis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Necrotising Enterocolitis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Necrotising Enterocolitis covered in this report include GlaxoSmithKline, Pfizer, Eli Lilly And Company, Bayer HealthCare, Becton, Dickinson And Company, Bristol-Myers Squibb Company and Medtronic, etc.
The global Necrotising Enterocolitis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Pfizer
Eli Lilly And Company
Bayer HealthCare
Becton, Dickinson And Company
Bristol-Myers Squibb Company
Medtronic
Global Necrotising Enterocolitis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Necrotising Enterocolitis market, Segment by Type:
Stage I
Stage II
Stage III
Global Necrotising Enterocolitis market, by Application
Hospital & Clinic
Diagnostic Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Necrotising Enterocolitis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Necrotising Enterocolitis
1.1 Necrotising Enterocolitis Market Overview
1.1.1 Necrotising Enterocolitis Product Scope
1.1.2 Necrotising Enterocolitis Market Status and Outlook
1.2 Global Necrotising Enterocolitis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Necrotising Enterocolitis Market Size by Region (2018-2029)
1.4 Global Necrotising Enterocolitis Historic Market Size by Region (2018-2023)
1.5 Global Necrotising Enterocolitis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Necrotising Enterocolitis Market Size (2018-2029)
1.6.1 North America Necrotising Enterocolitis Market Size (2018-2029)
1.6.2 Europe Necrotising Enterocolitis Market Size (2018-2029)
1.6.3 Asia-Pacific Necrotising Enterocolitis Market Size (2018-2029)
1.6.4 Latin America Necrotising Enterocolitis Market Size (2018-2029)
1.6.5 Middle East & Africa Necrotising Enterocolitis Market Size (2018-2029)
2 Necrotising Enterocolitis Market by Type
2.1 Introduction
2.1.1 Stage I
2.1.2 Stage II
2.1.3 Stage III
2.2 Global Necrotising Enterocolitis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Necrotising Enterocolitis Historic Market Size by Type (2018-2023)
2.2.2 Global Necrotising Enterocolitis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Necrotising Enterocolitis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Necrotising Enterocolitis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Necrotising Enterocolitis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Necrotising Enterocolitis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Necrotising Enterocolitis Revenue Breakdown by Type (2018-2029)
3 Necrotising Enterocolitis Market Overview by Application
3.1 Introduction
3.1.1 Hospital & Clinic
3.1.2 Diagnostic Center
3.2 Global Necrotising Enterocolitis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Necrotising Enterocolitis Historic Market Size by Application (2018-2023)
3.2.2 Global Necrotising Enterocolitis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Necrotising Enterocolitis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Necrotising Enterocolitis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Necrotising Enterocolitis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Necrotising Enterocolitis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Necrotising Enterocolitis Revenue Breakdown by Application (2018-2029)
4 Necrotising Enterocolitis Competition Analysis by Players
4.1 Global Necrotising Enterocolitis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Necrotising Enterocolitis as of 2022)
4.3 Date of Key Players Enter into Necrotising Enterocolitis Market
4.4 Global Top Players Necrotising Enterocolitis Headquarters and Area Served
4.5 Key Players Necrotising Enterocolitis Product Solution and Service
4.6 Competitive Status
4.6.1 Necrotising Enterocolitis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Necrotising Enterocolitis Products, Services and Solutions
5.1.4 GlaxoSmithKline Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Necrotising Enterocolitis Products, Services and Solutions
5.2.4 Pfizer Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Eli Lilly And Company
5.3.1 Eli Lilly And Company Profile
5.3.2 Eli Lilly And Company Main Business
5.3.3 Eli Lilly And Company Necrotising Enterocolitis Products, Services and Solutions
5.3.4 Eli Lilly And Company Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer HealthCare Recent Developments
5.4 Bayer HealthCare
5.4.1 Bayer HealthCare Profile
5.4.2 Bayer HealthCare Main Business
5.4.3 Bayer HealthCare Necrotising Enterocolitis Products, Services and Solutions
5.4.4 Bayer HealthCare Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer HealthCare Recent Developments
5.5 Becton, Dickinson And Company
5.5.1 Becton, Dickinson And Company Profile
5.5.2 Becton, Dickinson And Company Main Business
5.5.3 Becton, Dickinson And Company Necrotising Enterocolitis Products, Services and Solutions
5.5.4 Becton, Dickinson And Company Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.5.5 Becton, Dickinson And Company Recent Developments
5.6 Bristol-Myers Squibb Company
5.6.1 Bristol-Myers Squibb Company Profile
5.6.2 Bristol-Myers Squibb Company Main Business
5.6.3 Bristol-Myers Squibb Company Necrotising Enterocolitis Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Company Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Company Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Necrotising Enterocolitis Products, Services and Solutions
5.7.4 Medtronic Necrotising Enterocolitis Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
6 North America
6.1 North America Necrotising Enterocolitis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Necrotising Enterocolitis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Necrotising Enterocolitis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Necrotising Enterocolitis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Necrotising Enterocolitis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Necrotising Enterocolitis Market Dynamics
11.1 Necrotising Enterocolitis Industry Trends
11.2 Necrotising Enterocolitis Market Drivers
11.3 Necrotising Enterocolitis Market Challenges
11.4 Necrotising Enterocolitis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
